The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
A Randomized Trial of Icatibant in ACE-Inhibitor–Induced Angioedema
Open accessAbstract
BACKGROUND: Angioedema induced by treatment with angiotensin-converting-enzyme (ACE) inhibitors accounts for one third of angioedema cases in the emergency room; it is usually manifested in the upper airway and the head and neck region. There is no approved treatment for this potentially life-threatening condition. METHODS: In this multicenter, double-blind, double-dummy, randomized phase 2 study, we assigned patients who had ACE-inhibitor-induced angioedema of the upper aerodigestive tract to treatment with 30 mg of subcutaneous icatibant, a selective bradykinin B2 receptor antagonist, or to the current off-label standard therapy consisting of intravenous prednisolone (500 mg) plus clemastine (2 mg). The primary efficacy end point was the median time to complete resolution of edema. RESULTS: All 27 patients in the per-protocol population had complete resolution of edema. The median time to complete resolution was 8.0 hours (interquartile range, 3.0 to 16.0) with icatibant as compared with 27.1 hours (interquartile range, 20.3 to 48.0) with standard therapy (P=0.002). Three patients receiving standard therapy required rescue intervention with icatibant and prednisolone; 1 patient required tracheotomy. Significantly more patients in the icatibant group than in the standard-therapy group had complete resolution of edema within 4 hours after treatment (5 of 13 vs. 0 of 14, P=0.02). The median time to the onset of symptom relief (according to a composite investigator-assessed symptom score) was significantly shorter with icatibant than with standard therapy (2.0 hours vs. 11.7 hours, P=0.03). The results were similar when patient-assessed symptom scores were used. CONCLUSIONS: Among patients with ACE-inhibitor-induced angioedema, the time to complete resolution of edema was significantly shorter with icatibant than with combination therapy with a glucocorticoid and an antihistamine. (Funded by Shire and the Federal Ministry of Education and Research of Germany; ClinicalTrials.gov number, NCT01154361.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kostis, J. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2003.09.014 · Cited by 579
Icatibant, a New Bradykinin-Receptor Antagonist, in Hereditary Angioedema
Cicardi, M., Banerji, A., Bracho, F., Malbrán, A., Rosenkranz, B., Riedl, M., Bork, K., Lumry, W., Aberer, W., Bier, H., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0906393 · Cited by 564
Self-citationGainer, J. V., Morrow, J. D., Loveland, A., King, D. J., & Brown, N. J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810293391804 · Cited by 443
Hubert, C., Houot, A. M., Corvol, P., & Soubrier, F. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98626-6 · Cited by 426
Clinical Profile of Angioedema Associated With Angiotensin Converting-Enzyme Inhibition
Slater, E. E. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410070095035 · Cited by 370
ACE Inhibitor???Induced Angioedema: Incidence, Prevention and Management
Vleeming, W., van Amsterdam, J. G. C., Stricker, B. H., & de Wildt, D. J. (1998) · Drug Safety · doi:10.2165/00002018-199818030-00003 · Cited by 243
Angioedema Incidence in US Veterans Initiating Angiotensin-Converting Enzyme Inhibitors
Miller, D. R., Oliveria, S. A., Berlowitz, D. R., Fincke, B. G., Stang, P., & Lillienfeld, D. E. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.110270 · Cited by 238
Banerji, A., Clark, S., Blanda, M., LoVecchio, F., Snyder, B., & Camargo, C. A. (2008) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)60594-7 · Cited by 236
Toh, S., Reichman, M. E., Houstoun, M., Ross Southworth, M., Ding, X., Hernandez, A. F., Levenson, M., Li, L., McCloskey, C., Shoaibi, A., et al. (2012) · Archives of Internal Medicine · doi:10.1001/2013.jamainternmed.34 · Cited by 215
Bas, M., Greve, J., Stelter, K., Bier, H., Stark, T., Hoffmann, T. K., & Kojda, G. (2010) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2010.03.032 · Cited by 164
Self-citationHoover, T. A., Lippmann, M. L., Grouzmann, E., Marceau, F., & Herscu, P. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2009.03323.x · Cited by 137
Dean, D., Schultz, D., & Powers, R. (2001) · Journal of Forensic Sciences · doi:10.1520/jfs15129j · Cited by 112
Nosbaum, A., Bouillet, L., Floccard, B., Javaud, N., Launay, D., Boccon‐Gibod, I., & Fain, O. (2013) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2012.12.017 · Cited by 55
Schmidt, P. W., Hirschl, M. M., & Trautinger, F. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.03.023 · Cited by 48
Dasarathy, Y., Lanzillo, J. J., & Fanburg, B. L. (1992) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1992.263.6.l645 · Cited by 47
Gallitelli, M., & Alzetta, M. (2011) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2011.09.014 · Cited by 38
Durch ACE-Hemmer induziertes Angio�dem des Kopf-Hals-Bereichs: Eine Frage der Zeit?
Baş, M., Kojda, G., Bier, H., & Hoffmann, T. K. (2004) · HNO · doi:10.1007/s00106-003-1017-5 · Cited by 25
Self-citationJavaud, N., Fain, O., Bernot, B., Adnet, F., & Lapostolle, F. (2011) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/j.annfar.2011.07.005 · Cited by 10
„Angiotensin-converting-enzyme“-Hemmer induziertes Angioödem
Baş, M., Kojda, G., & Stelter, K. (2010) · Der Anaesthesist · doi:10.1007/s00101-010-1798-3 · Cited by 9
Self-citation
Cited by
Maurer, M., Magerl, M., Ansotegui, I., Aygören‐Pürsün, E., Betschel, S., Bork, K., Bowen, T., Balle Boysen, H., Farkas, H., Grumach, A. S., et al. (2018) · Allergy · doi:10.1111/all.13384 · Cited by 513
Arendse, L. B., Danser, A. H. J., Poglitsch, M., Touyz, R. M., Burnett, J. C., Llorens-Cortes, C., Ehlers, M. R., & Sturrock, E. D. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.017129 · Cited by 339
Metadata
- Authors
- Baş, M., Greve, J., Stelter, K., Havel, M., Strassen, U., Rotter, N., Veit, J., Schossow, B., Hapfelmeier, A., Kehl, V., Kojda, G., & Hoffmann, T. K.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-01-29
- Volume
- 372
- Issue
- 5
- Pages
- 418-425
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2166848757
- Cited by
- 253
- References
- 19
- FWCI
- 18.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.